Cristóbal, H.; Enjuanes, C.; Batlle, M.; Tajes, M.; Campos, B.; Francesch, J.; Moliner, P.; Farrero, M.; Andrea, R.; Ortiz-Pérez, J.T.;
et al. Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction. J. Pers. Med. 2023, 13, 446.
https://doi.org/10.3390/jpm13030446
AMA Style
Cristóbal H, Enjuanes C, Batlle M, Tajes M, Campos B, Francesch J, Moliner P, Farrero M, Andrea R, Ortiz-Pérez JT,
et al. Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction. Journal of Personalized Medicine. 2023; 13(3):446.
https://doi.org/10.3390/jpm13030446
Chicago/Turabian Style
Cristóbal, Helena, Cristina Enjuanes, Montserrat Batlle, Marta Tajes, Begoña Campos, Josep Francesch, Pedro Moliner, Marta Farrero, Rut Andrea, José Tomás Ortiz-Pérez,
and et al. 2023. "Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction" Journal of Personalized Medicine 13, no. 3: 446.
https://doi.org/10.3390/jpm13030446
APA Style
Cristóbal, H., Enjuanes, C., Batlle, M., Tajes, M., Campos, B., Francesch, J., Moliner, P., Farrero, M., Andrea, R., Ortiz-Pérez, J. T., Morales, A., Sabaté, M., Comin-Colet, J., & GarcÃa de Frutos, P.
(2023). Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction. Journal of Personalized Medicine, 13(3), 446.
https://doi.org/10.3390/jpm13030446
